NASDAQ:KYTX
Kyverna Therapeutics Inc (KYTX) Becoming More Attractive for Investors
Kyverna Therapeutics Inc’s filing revealed that its Director SEIDENBERG BETH C acquired Company’s shares for reported $1.0 million on Dec ...
Kyverna Therapeutics Inc’s latest rating changes from various analysts
Kyverna Therapeutics Inc’s filing revealed that its Director SEIDENBERG BETH C acquired Company’s shares for reported $1.0 million on Dec ...
Analyzing Kyverna Therapeutics Inc (KYTX) After Recent Trading Activity
In a filing, Kyverna Therapeutics Inc revealed its Director SEIDENBERG BETH C acquired Company’s shares for reported $1.0 million on ...
Investing in Kyverna Therapeutics Inc (KYTX): What You Must Know
In a filing, Kyverna Therapeutics Inc revealed its Director SEIDENBERG BETH C acquired Company’s shares for reported $1.0 million on ...
Recent Insider Activity Could Benefit Kyverna Therapeutics Inc (KYTX)
Kyverna Therapeutics Inc’s filing revealed that its Director SEIDENBERG BETH C acquired Company’s shares for reported $1.0 million on Dec ...
Understanding the Risks of Investing in Kyverna Therapeutics Inc (KYTX)
Kyverna Therapeutics Inc’s filing revealed that its Director SEIDENBERG BETH C acquired Company’s shares for reported $1.0 million on Dec ...
